T. Rowe Price Associates’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106M | Sell |
4,479,717
-275,115
| -6% | -$6.48M | 0.01% | 559 |
|
|
2025
Q1 | $114M | Buy |
4,754,832
+377,783
| +9% | +$9.07M | 0.01% | 530 |
|
|
2024
Q4 | $185M | Buy |
4,377,049
+437,940
| +11% | +$18.5M | 0.02% | 448 |
|
|
2024
Q3 | $174M | Buy |
3,939,109
+318,974
| +9% | +$14.1M | 0.02% | 455 |
|
|
2024
Q2 | $131M | Buy |
3,620,135
+1,227,106
| +51% | +$44.4M | 0.02% | 487 |
|
|
2024
Q1 | $103M | Buy |
+2,393,029
| New | +$103M | 0.01% | 544 |
|